office (813) 745-6239
fax (813) 745-6525


Economics is the science of choice and cancer is a disease that involves many perplexing choices. Our lab is one of the few devoted to cancer economics. Specifically, we study patients' preferences so that we can improve patient care. Our lab achieves this goal by conducting health preference surveys, economic evaluations, and secondary data analyses on a wide range of cancer-related topics (See Curriculum Vitae). As the examples below show, we collaborate with a diverse group of peers "to contribute to the prevention and cure of cancer."



Dr. Craig is the director of Craig Lab. In September 2011 the National Cancer Institute (NCI) awarded Dr. Craig a 5-year NIH R01 grant (R01CA160104) to conduct a national valuation study of the Patient-Reported Outcomes Measurement Information System--assessment tools that measure patient-reported health status--which was funded by the National Institutes of Health (NIH). Click here

Benjamin M. Craig, Ph.D.
Associate Member, Department of Health Outcomes and Behavior, Moffitt Cancer Center
Associate Professor of Economics at the University of South Florida 



Craig Lab provided support to Dr. Brandon with his NCI-funded (R01-CA134347) study examining the cost-effectiveness of extended self-help booklets for smoking cessation. Prior to this research, Craig Lab provided support to his analysis of the cost-effectiveness of relapse-prevention booklets as adjunct to a tobacco quitline (R01-CA137357).    

Thomas H. Brandon, Ph.D.
Chair, Program Leader, and Senior Member, Department of Health Outcomes and Behavior
Moffitt Cancer Center


Craig Lab is currently collaborating with Dr. Gilbert on a valuation study to assess preferences on urinary function among patients diagnosed with bladder cancer. Additionally, both Drs. Craig and Gilbert are members of the Genitourinary Cancer Outcomes Research (GCOR) group, which consists of internal and external collaboratotrs dedicated to quality of life research in genitourinary oncology.

   Scott M. Gilbert, MD
   Associate Member, Genitourinary Oncology Program, Moffitt Cancer Center


Craig Lab collaborated with Dr. Lengacher on a study that looked at the cost-effectiveness of a Mindfulness-Based Stress Reduction program for improving quality of life in breast cancer survivors.

Cecile A. Lengacher, RN, PhD, FAAN
Faculty Member, Health Outcomes and Behavior Program, Breast Cancer Clinical Program and Population Sciences Division, Moffitt Cancer Center
Professor and Director of the BS-PhD Program, College of Nursing at the University of South Florida


Craig Lab collaborated with Dr. List on three analyses of Medicare claims data from the Surveillance Epidemiology and End Results (SEER) system, each of which examined the registration of patients diagnosed with hematologic disorders: 1) Assessment of accurate reporting of myeloid leukemias in the 1999-2008 SEER-Medicare database (abstract) 2) Incidence of myelodysplastic syndromes using the 2000-2008 SEER-Medicare database (abstract) and 3) Comparison of myelodysplastic syndrome patients registered versus not registered in SEER with regard to diagnostic testing, treatment, cost of care, and survival (abstract).

   Alan F. List, M.D.
   President and CEO of Moffitt Cancer Center
   Senior Member, Department of Malignant Hematology and the Experimental Therapeutics Program

Craig Lab recently submitted a Patient-Centered Outcomes Research Institute (PCORI) grant proposal with Dr. Magliocco to investigate “patient-centered strategies to reduce the diagnostic burden in breast cancer pathology.” Drs. Magliocco and Craig seek to identify the frequency and extent of diagnostic differences in referred specimens of  breast cancer patients treated at Moffitt Cancer Center and to assess patient burden of misdiagnoses. Additionally, they plan to model the comparative benefits and harms of alternative referral strategies in terms of reduced likelihood of improper medical treatment and reduced diagnostic burden. For this study, Craig Lab will be conducting a patient-centered online survey of approximately 1,000 U.S. women age 40 or older.

Anthony M. Magliocco, M.D., F.R.C.P.C., F.C.A.P.
Chair, Anatomic Pathology and Executive Director of Esoteric Laboratory Services
Moffitt Cancer Center



Craig Lab and Dr. Pidala developed an instrument to survey oncologists and hematologists using best-worst scaling of clinical vignettes that described a variety of patient characteristics to assess referral practices for hematopoietic cell transplantation (abstract).

Joseph A. Pidala, M.D., M.S.
Associate Member, Blood and Marrow Transplant Department, Moffitt Cancer Center


Craig Lab is currently collaborating with Dr. Poch on a valuation study to assess the preferences of patients diagnosed with bladder cancer on outcomes related to body image following urinary reconstruction and diversion. Participating patients are surveyed both before and after the procedure.

Michael A. Poch, M.D.
Assistant Member, Geniotourinary Oncology Program, Moffitt Cancer Center


Craig Lab and Dr. Reed examined the sociodemographic factors correlated with infertility treatment using the National Survey of Family Growth (NSFG) dataset (abstract). More recently, Craig Lab and Reed conducted an online survey to look at whether or not having had a meningioma influenced womens' pregnancy desires and intentions (abstract). Next, Drs. Craig and Reed will look at the survey data to assess the association between meningioma and pregnancy. Lastly, Craig Lab has participated in social support events for the Adolescent Young Adult (AYA) program at Moffitt, directed by Dr. Reed.



Damon R. Reed, M.D.
Assistant Member, Sarcoma Program, Moffitt Cancer Center